Investment Advisors Buy $3.97M in Pfizer Shares After Q Earnings Beat
The firm purchased 165,000 Pfizer shares valued at about $3.97M. HFM Investment Advisors added to its position, bringing holdings to 1,127 shares worth roughly $28,000, while Darwin Wealth Management acquired a new position valued near $32,000. Pfizer reported $0.77 EPS versus $0.68 expected and $15.03B revenue vs $14.40B, with some analysts noting improving pipeline outlook despite a lowered price objective.